DiaMedica Therapeutics Inc. (DMAC) Reports In-Line Q1 EPS

DiaMedica Therapeutics Inc. (NASDAQ: DMAC) reported Q1 EPS of ($0.19), in-line with the analyst estimate of ($0.19).

For earnings history and earnings-related data on DiaMedica Therapeutics Inc. (DMAC) click here.

You May Also Be Interested In

• Deere conference call: 2027 orders up mid-single digits from last year)
• 'We expect salesforce.com (CRM) to capture a meaningful share of next-gen agentic workflows': Cantor
• Rubrik Inc (RBRK) PT Raised to $120 at Cantor Fitzgerald Into Q2 Earnings